Comparison of Diagnostic Performance Between Standard Susceptibility Map‐Weighted Imaging and Susceptibility Map‐Weighted Imaging Reconstructed From Clinical SWI and Neuromelanin MRI in Early Parkinson's Disease
Journal of Magnetic Resonance Imaging · 2026-08 · 64 (2) · 404-412
DOI: 10.1002/jmri.70332 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Magnetic Resonance Imaging, online erschienen am 15.04.2026. Verfasst von Seon Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Parkinson Disease, Melanins, Magnetic Resonance Imaging, Image Processing, Computer-Assisted. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Research Foundation of Korea (NRF), Ministry of Health & Welfare, Ministry of Health and Welfare.
Abstract (Originalsprache)
Background
Susceptibility map‐weighted imaging (SMwI) provides high accuracy for early Parkinson's disease (ePD) by enhancing nigral hyperintensity. However, standard SMwI requires dedicated acquisition; reconstruction from routinely acquired sequences may offer a practical alternative.
Purpose
To compare the diagnostic performance of standard SMwI with SWI‐ and neuromelanin (NM)‐driven SMwI for differentiating ePD from disease controls (DC). Study Type Retrospective. Subjects One hundred and eighty‐seven drug‐naïve ePD (age: 67.5 ± 9.4 years, 102 male) and 43 DC (age: 67.1 ± 9.2 years, 12 male). Field Strength/Sequence 3 T, multi‐echo gradient‐echo (GRE) for standard SMwI; GRE‐based NM imaging: multi‐echo GRE for SWI. Assessment Nigral hyperintensity was assessed by three neuroradiologists (4‐, 2‐, and 1‐year experience). Diagnostic performance was evaluated using clinical diagnosis for all subjects and PET for 106 subjects (98 ePD, 8 DC). PET‐based assessment included side‐based analyses accounting for PET laterality and patient‐based analyses regardless of direction. Statistical Tests Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), accuracy and area under the curve (AUC) were assessed using clinical diagnosis as reference; sensitivity, specificity, and accuracy using PET. Significance was set at p < 0.05.
Results
Using clinical diagnosis as reference, standard SMwI showed highest diagnostic performance (sensitivity 0.856; specificity 1.000; PPV 1.000; AUC 0.928). SWI‐driven SMwI maintained similar sensitivity ( p = 0.355) but showed significantly reduced specificity, PPV, accuracy, AUC. In the PET subgroup, side‐ and patient‐based analyses showed no differences in sensitivity ( p = 0.261, p = 0.670), specificity ( p = 1.000, p = 1.000) and accuracy ( p = 0.268, p = 0.695) between standard and SWI‐driven SMwI. Data Conclusion SWI‐driven SMwI approached the diagnostic performance of standard SMwI with PET reference but showed inferior performance with clinical diagnosis, suggesting a fallback option when dedicated SMwI is unavailable. Evidence Level 3. Technical Efficacy Stage 1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
- Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
- Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
- Research Institute for Future Medicine, Samsung Medical Center, Seoul, Republic of Korea.
ORCID-Profile: Seon Lee, Yongsik Sim, Jinyoung Youn, Eung Yeop Kim, Seung Hwan Moon, Sun-Young Baek, Beomseok Sohn
Förderung
- National Research Foundation of Korea (NRF)
- Ministry of Health & Welfare
- Ministry of Health and Welfare
- Korea Health Industry Development Institute
Zitieren
APA
Lee, S., Sim, Y., Youn, J., Kim, E. Y., Moon, S. H., Baek, S. Y., & Sohn, B. (2026). Comparison of Diagnostic Performance Between Standard Susceptibility Map‐Weighted Imaging and Susceptibility Map‐Weighted Imaging Reconstructed From Clinical SWI and Neuromelanin MRI in Early Parkinson's Disease. Journal of Magnetic Resonance Imaging, 64(2), 404-412. https://doi.org/10.1002/jmri.70332
Vancouver
Lee S, Sim Y, Youn J, Kim EY, Moon SH, Baek SY, et al. Comparison of Diagnostic Performance Between Standard Susceptibility Map‐Weighted Imaging and Susceptibility Map‐Weighted Imaging Reconstructed From Clinical SWI and Neuromelanin MRI in Early Parkinson's Disease. Journal of Magnetic Resonance Imaging. 2026;64(2):404-412. doi:10.1002/jmri.70332
BibTeX
@article{Lee2026,
author = {Lee, Seon and Sim, Yongsik and Youn, Jinyoung and Kim, Eung Yeop and Moon, Seung Hwan and Baek, Sun-Young and Sohn, Beomseok},
title = {Comparison of Diagnostic Performance Between Standard Susceptibility Map‐Weighted Imaging and Susceptibility Map‐Weighted Imaging Reconstructed From Clinical SWI and Neuromelanin MRI in Early Parkinson's Disease},
journal = {Journal of Magnetic Resonance Imaging},
year = {2026},
volume = {64},
number = {2},
pages = {404--412},
doi = {10.1002/jmri.70332}
}
EUVIMED